Osaka, Japan

Naruto Katsuragi

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 103(Granted Patents)


Location History:

  • Ibaraki, JP (2010)
  • Osaka, JP (2011 - 2013)
  • Hyogo, JP (2019)

Company Filing History:


Years Active: 2010-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Naruto Katsuragi

Introduction

Naruto Katsuragi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibodies for treating inflammation-associated diseases. With a total of 4 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Katsuragi's latest patents include an antibody against a peptide encoded by Exon-21 of periostin and a pharmaceutical composition for preventing or treating inflammation-associated diseases. The first patent provides a drug aimed at preventing or treating inflammation-related diseases involving a periostin isoform with cell adhesion activity. The second patent focuses on an antibody against periostin, which neutralizes its anti-cell adhesive properties. This invention also includes methods for detecting and quantifying the periostin isoform in samples, as well as diagnosing periostin-related diseases.

Career Highlights

Throughout his career, Katsuragi has worked with notable institutions such as Osaka University and Daiichi Sankyo Company, Limited. His research has been pivotal in advancing the understanding of periostin and its role in various diseases.

Collaborations

Katsuragi has collaborated with esteemed colleagues, including Ryuichi Morishita and Yoshiaki Taniyama. Their combined expertise has contributed to the success of his innovative projects.

Conclusion

Naruto Katsuragi's work exemplifies the intersection of innovation and healthcare. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…